intermune

InterMune may receive $60 per share takeover offer

acquisition, analysis, business, esbriet, financial news, glaxosmithkline, gsk, hgsi, human genome sciences, intermune, itmn, market, merger, stock, trading

Rumors are swirling that InterMune will receive a $60 per share takeover offer. Several major drug companies are looking at InterMune following the FDA approval of its lung disease drug Esbriet. Industry sources say GlaxoSmithKlin

By FNNO Staff
fnnonline@gmail.com

Options Report: March 4th, 2011

call, cedc, colgate-palmolive, etf, eu, fda, finance, gilead sciences, ibm, intermune, jpmorgan chase, news, nuance communications, options, puts, report, s&p, southwest airlines, tivo, yrc worldwide

Welcome to the Financial News Network Options Report. On the call side, Nuance Communications is seeing 11.5 times the normal amount of calls today news that the company is forming a partnership with IBM. Southwest Airlines shares

By Stephanie Shyu
sshyu@fnno.com

InterMune Misses Q4 EPS Estimates, Guidance Awaits FDA

Published on Wed, 02/16/2011 - 17:00
By FNNO Staff in General Interest, analysis, business, earnings, eps, financial, intermune, itmn, market, news, stock, trading, Earnings Reports

InterMune currently expects to provide full-year 2011 guidance after the company meets with the FDA in March 2011 and finalizes the details of its U.S.

analysis, business, earnings, eps, financial, intermune, itmn, market, news, stock, trading

InterMune (NASDAQ:ITMN) reported Q4 EPS of 56 cents, ex-items, missing consensus estimates of 64 cents. Sales totaled $242 million.

By FNNO Staff
fnnonline@gmail.com

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Watch for Continued Losses in Shares of ...

Quiksilver (NYSE:ZQK) traded at a new 52-week low today of $1.39. Approximately 1.4 mi ...

Shares of YRC Worldwide Fall Below Previ...

YRC Worldwide (NASDAQ:YRCW) traded at a new 52-week low today of $13.70. This new low ...

Recent 52-Week Low Surpassed in Shares o...

Wynn Resorts (NASDAQ:WYNN) traded today at a new 52-week low of $102.92. So far today ...

Recent 52-Week High Exceeded in Shares o...

Universal Health Services (NYSE:UHS) traded today at a new 52-week high of $131.59. So ...

Shares of Techne Rise Above Previous 52-...

Techne (NASDAQ:TECH) traded at a new 52-week high today of $103.56. So far today appro ...

Skyworks Solutions Looks to Continue to ...

Skyworks Solutions (NASDAQ:SWKS) traded today at a new 52-week high of $106.97. This n ...

Shares of The Inventure Group Fall Below...

Shares of The Inventure Group (NASDAQ:SNAK) traded today at $8.51, breaking its 52-week ...

Watch for Continued Gains in Shares of O...

Shares of Orbotech (NASDAQ:ORBK) traded at a new 52-week high today of $20.41. So far ...

Most Popular Video News